Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Dr Soliman Abdul Kader Fakeeh Hospital Co EBITDA Margin %?
Dr Soliman Abdul Kader Fakeeh Hospital CoSAU:4017 +1.12%15 EBITDA Margin % is 16.07% as of Jun. 2026, which is 18% below its 10-year median of 19.55. GuruFocus rates SAU:4017 with a GF Score™ of 15/100. The stock has 3 warning signs investors should review. Among 671 Healthcare Providers & Services companies, Dr Soliman Abdul Kader Fakeeh Hospital Co ranks better than 63.93% on this metric.
Dr Soliman Abdul Kader Fakeeh Hospital Co (SAU:4017) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Dr Soliman Abdul Kader Fakeeh Hospital Co EBITDA Margin % Related Terms
Dr Soliman Abdul Kader Fakeeh Hospital Co EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dr Soliman Abdul Kader Fakeeh Hospital Co EBITDA Margin % Chart
Dr Soliman Abdul Kader Fakeeh Hospital Co Annual Data
Trend
Dec23
Dec24
Dec25
EBITDA Margin %
22.62
19.55
16.55
Dr Soliman Abdul Kader Fakeeh Hospital Co Quarterly Data
SAU:4017 vs HCA, THC, EHC: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, Dr Soliman Abdul Kader Fakeeh Hospital Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dr Soliman Abdul Kader Fakeeh Hospital Co EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Dr Soliman Abdul Kader Fakeeh Hospital Co's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Dr Soliman Abdul Kader Fakeeh Hospital Co's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dr Soliman Abdul Kader Fakeeh Hospital Co (SAU:4017) has a EBITDA Margin % of 16.07% as of Jun. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Dr Soliman Abdul Kader Fakeeh Hospital Co and its competitors. This is 18% below median its historical median of 19.55. Over the past decade, Dr Soliman Abdul Kader Fakeeh Hospital Co's EBITDA Margin % has ranged from 15.56 to 22.62. According to the industry distribution chart, Dr Soliman Abdul Kader Fakeeh Hospital Co ranks #242 out of 671 companies in the Healthcare Providers & Services industry, placing it in the top 36.1%.
Is Dr Soliman Abdul Kader Fakeeh Hospital Co's EBITDA Margin % too high?
Dr Soliman Abdul Kader Fakeeh Hospital Co's current EBITDA Margin % of 16.07% is 18% below median its 10-year median of 19.55. Over the past 10 years, this metric has ranged from a low of 15.56 to a high of 22.62. The Healthcare Providers & Services industry median EBITDA Margin % is 10.09. Dr Soliman Abdul Kader Fakeeh Hospital Co's value of 16.07% is 59.3% above this industry median. Based on the distribution chart, Dr Soliman Abdul Kader Fakeeh Hospital Co ranks #242 out of 671 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Dr Soliman Abdul Kader Fakeeh Hospital Co has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Dr Soliman Abdul Kader Fakeeh Hospital Co's EBITDA Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Dr Soliman Abdul Kader Fakeeh Hospital Co ranks #242 out of 671 companies for EBITDA Margin %. This puts Dr Soliman Abdul Kader Fakeeh Hospital Co in the upper half of its industry. The industry median EBITDA Margin % is 10.09. Dr Soliman Abdul Kader Fakeeh Hospital Co's value of 16.07% is 59.3% above this benchmark. Historically, Dr Soliman Abdul Kader Fakeeh Hospital Co's own EBITDA Margin % has ranged from 15.56 to 22.62 over the past decade. While the company's 10-year median is 19.55 vs. the industry median of 10.09, Dr Soliman Abdul Kader Fakeeh Hospital Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.09, based on 671 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dr Soliman Abdul Kader Fakeeh Hospital Co's current EBITDA Margin % of 16.07% is 59.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Dr Soliman Abdul Kader Fakeeh Hospital Co and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dr Soliman Abdul Kader Fakeeh Hospital Co's current EBITDA Margin % is 16.07%, which is 18% below median its own 10-year median of 19.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dr Soliman Abdul Kader Fakeeh Hospital Co stock overvalued right now?
Dr Soliman Abdul Kader Fakeeh Hospital Co (SAU:4017) has a current EBITDA Margin % of 16.07%. The current EBITDA Margin % is 16.07%, which is 18% below median its 10-year median of 19.55 and 59.3% above the Healthcare Providers & Services industry median of 10.09. Dr Soliman Abdul Kader Fakeeh Hospital Co's overall GF Score™ is 15/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Dr Soliman Abdul Kader Fakeeh Hospital Co (SAU:4017), the current EBITDA Margin % is 16.07% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Dr Soliman Abdul Kader Fakeeh Hospital Co is a company whose principal activities include managing, establishing, and operating hospitals, clinics, medical, educational, and training centers. In addition to the above, the company is also managing and operating medical services, analysis and radiology laboratory, and managing and establishing pharmacies, wholesale and retail of medical equipment, maintenance of IT equipment, and software-related services. The group has three reportable segments, including medical services, which generates maximum revenue, education, trading, retail, and others. Geographically, it principally operates in the Kingdom of Saudi Arabia.
15GF Score
Get the complete analysis for SAU:4017
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAU:4017 has been successfully added to your 
